shars are getting locked up, no one wants to sell, only the bashers shake the tree, and,
Amarantus BioScience (AMBS) Target Price After Potential Pfizer (PFE) Acquisition $2.70 Projects Biotech News Stock Review.
Adam crunched the numbers and it looks very impressive for AMBS if Pfizer purchases them. The first week of February could be very exciting for AMBS shareholders as we believe that PFE is meeting with AMBS in NYC, watch for official press releases around that time frame.